New Alliance: FCF Life Sciences & Bioscience Valuation
FCF Fox Corporate Finance forms strategic alliance with BioScience Valuation BSV Munich/Grainau, May 20th, 2020 – The Life Sciences team at Fox Corporate Finance GmbH (“FCF”) is collaborating with BioScience Valuation BSV GmbH (“BSV”) as
FCF Life Sciences Venture Capital Monitor – 04/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 04/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,
FCF Life Sciences partners with YAFO Capital
We are happy to announce our partnership with YAFO Capital, a China-focused life sciences specialist. Today, YAFO is part of our global network, providing access to financial and strategic life sciences investors. Similar to our
FCF Life Sciences Venture Capital Monitor – 03/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 03/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,
FCF Valuation Monitor – Q1 2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q1 2020”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and
FCF Fox Corporate Finance GmbH advises ROBART GmbH on venture debt financing
Linz/Munich, 27 March 2020 – FCF Fox Corporate Finance is acting as advisor to ROBART GmbH, an Austrian growth company in the field of robotics, in the execution of a venture debt financing with the